Jordi Esteve
- Hematology top 0.1%
- Acute Myeloid Leukemia Research 146
- Hematopoietic Stem Cell Transplantation 67
- Chronic Myeloid Leukemia Treatments 50
- Multiple Myeloma Research and Treatments 26
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 40
- Myeloproliferative Neoplasms: Diagnosis and Treatment 26
-
- Lymphoma Diagnosis and Treatment 37
- Oncology top 1%
- Biochemistry top 1%
-
- Acute Lymphoblastic Leukemia research 69
- Co-authors
- Dolors ColomerEmili MontserratMohamad MohtyArnon NaglerMyriam LabopinSalut BrunetNeus VillamorElı́as Campo
- Journals
- Journal of Clinical Oncology (6 papers)SHILAP Revista de lepidopterología (2 papers)Blood (52 papers)
In The Last Decade
Jordi Esteve
248 papers receiving 7.5k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Hematology 4.9k
- Genetics 1.8k
- Pathology and Forensic Medicine 1.2k
- Oncology 1.8k
- Biochemistry 340
Countries citing papers authored by Jordi Esteve
This map shows the geographic impact of Jordi Esteve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordi Esteve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordi Esteve more than expected).
Fields of papers citing papers by Jordi Esteve
This network shows the impact of papers produced by Jordi Esteve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordi Esteve. The network helps show where Jordi Esteve may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jordi Esteve, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 5 | |
| 7 | 2023 | 13 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 11 | |
| 11 | 2022 | 9 | |
| 12 | 2022 | 31 | |
| 13 | 2021 | 19 | |
| 14 | 2021 | 8 | |
| 15 | 2020 | 39 | |
| 16 | 2020 | 1 | |
| 17 | 2020 | 6 | |
| 18 | 2019 | 23 | |
| 19 | Allogeneic stem cell transplantation in adult patients with acute myeloid leukemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European society of Blood and Marrow Transplantation (EBMT) | 2016 | 1 |
| 20 | 2006 | 91 |
About Jordi Esteve
Jordi Esteve is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 262 papers that have together received 7.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (146 papers), Acute Lymphoblastic Leukemia research (69 papers), Hematopoietic Stem Cell Transplantation (67 papers), Chronic Myeloid Leukemia Treatments (50 papers), Chronic Lymphocytic Leukemia Research (40 papers), Lymphoma Diagnosis and Treatment (37 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers) and Multiple Myeloma Research and Treatments (26 papers). The work is most often cited by research in Hematology (4.9k citations), Genetics (1.8k citations) and Pathology and Forensic Medicine (1.2k citations). Jordi Esteve has collaborated with scholars based in Spain, France and Israel. Frequent co-authors include Dolors Colomer, Emili Montserrat, Mohamad Mohty, Arnon Nagler, Myriam Labopin, Salut Brunet, Neus Villamor, Elı́as Campo, Josep‐María Ribera and Montserrat Rovira. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.